Boothbay Fund Management, LLC Aslan Pharmaceuticals LTD Transaction History

Boothbay Fund Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.42 - $24.68 $3,656 - $214,888	-8,707 Reduced 9.52%	82,763 $50,000
Q4 2021 Feb 14, 2022	SELL	$1.11 - $1.86 $106,995 - $179,289	-96,392 Reduced 51.31%	91,470 $102,000
Q3 2021 Nov 15, 2021	BUY	$1.78 - $3.41 $101,358 - $194,175	56,943 Added 43.49%	187,862 $334,000
Q2 2021 Aug 16, 2021	SELL	$2.5 - $3.72 $2 - $3	-1 Reduced -0.0%	130,919 $432,000
Q1 2021 May 17, 2021	SELL	$1.86 - $5.25 $149,811 - $422,856	-80,544 Reduced 38.09%	130,920 $439,000
Q4 2020 Feb 12, 2021	BUY	$1.54 - $2.22 $325,654 - $469,450	211,464 New	211,464 $387,000

Ticker ASLN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,744,704
Market Cap $41.8M
Description
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-m...

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Boothbay Fund Management, LLC with notifications on news.